MoneyWorks4Me

Sanjivani Paranteral informs about outcome of board meeting

20 Aug 2021 Evaluate
Sanjivani Paranteral has informed that Board of Directors of the Company at its meeting held on August 19, 2021, approved the allotment of 15,00,000 equity shares of face value of Rs 10 each (Equity Share) at a price of Rs 10 per Equity Share (including a premium of Rs nil per Equity Share) on a preferential basis, for an aggregate amount of Rs 1,50,00,000. More details enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..